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Global Regulator of Virulence A (GrvA) Coordinates Expression of
Discrete Pathogenic Mechanisms in Enterohemorrhagic Escherichia
coli through Interactions with GadW-GadE
Jason K. Morgan, Ronan K. Carroll, Carly M. Harro, Khoury W. Vendura, Lindsey N. Shaw, James T. Riordan
University of South Florida, Department of Cell Biology, Microbiology and Molecular Biology, Tampa, Florida, USA
ABSTRACT
Global regulator of virulence A (GrvA) is a ToxR-family transcriptional regulator that activates locus of enterocyte effacement
(LEE)-dependent adherence in enterohemorrhagic Escherichia coli (EHEC). LEE activation by GrvA requires the Rcs phosphore-
lay response regulator RcsB and is sensitive to physiologically relevant concentrations of bicarbonate, a known stimulant of vir-
ulence systems in intestinal pathogens. This study determines the genomic scale of GrvA-dependent regulation and uncovers
details of the molecular mechanism underlying GrvA-dependent regulation of pathogenic mechanisms in EHEC. In a grvA-null
background of EHEC strain TW14359, RNA sequencing analysis revealed the altered expression of over 700 genes, including the
downregulation of LEE- and non-LEE-encoded effectors and the upregulation of genes for glutamate-dependent acid resistance
(GDAR). Upregulation of GDAR genes corresponded with a marked increase in acid resistance. GrvA-dependent regulation of
GDAR and the LEE required gadE, the central activator of GDAR genes and a direct repressor of the LEE. Control of gadE by
GrvA was further determined to occur through downregulation of the gadE activator GadW. This interaction of GrvA with
GadW-GadE represses the acid resistance phenotype, while it concomitantly activates the LEE-dependent adherence and secre-
tion of immune subversion effectors. The results of this study significantly broaden the scope of GrvA-dependent regulation and
its role in EHEC pathogenesis.
IMPORTANCE
Enterohemorrhagic Escherichia coli (EHEC) is an intestinal human pathogen causing acute hemorrhagic colitis and life-threat-
ening hemolytic-uremic syndrome. For successful transmission and gut colonization, EHEC relies on the glutamate-dependent
acid resistance (GDAR) system and a type III secretion apparatus, encoded on the LEE pathogenicity island. This study investi-
gates the mechanism whereby the DNA-binding regulator GrvA coordinates activation of the LEE with repression of GDAR. In-
vestigating how these systems are regulated leads to an understanding of pathogenic behavior and novel strategies aimed at dis-
ease prevention and control.
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a viru-lent intestinal pathogen causing foodborne outbreaks of
bloody diarrhea (hemorrhagic colitis) and the life-threatening
kidney disease hemolytic-uremic syndrome (1–3). Competitive
colonization of the intestine by EHEC requires a type III secretion
(T3S) mechanism and is characterized by the formation of attach-
ing-and-effacing (A/E) lesions (1, 2). The T3S apparatus is en-
coded on a pathogenicity island, referred to as the locus of entero-
cyte effacement (LEE), containing 41 genes organized into five
operons (LEE1 to LEE5) (4). The master LEE regulator, Ler, en-
coded as the first gene of LEE1, positively stimulates LEE tran-
scription by relieving H-NS-mediated repression. Ler further ac-
tivates the LEE-encoded regulators GrlA and GrlR, which in turn
activate and repress ler transcription, respectively (5–10). Numer-
ous non-LEE-encoded regulators also converge on ler and grlA
promoters to coordinate LEE-dependent colonization with envi-
ronmental/physiological cues (11–19).
One such regulator, RcsB, has been shown to both activate and
repress LEE transcription and more recently has been shown to be
required for induction of the LEE in response to the bicarbonate
ion (20, 21). RcsB is the response regulator of the Rcs phosphore-
lay system, a multicomponent signaling pathway including RcsC
(sensor kinase), RcsD (histidine phosphotransferase), and RcsF
(outer membrane lipoprotein) (22–26). Upon phosphorylation,
RcsB can bind to target promoters as a homodimer and as a het-
erodimer in conjunction with other regulatory auxiliary proteins,
such as RcsA, BglJ, and GadE (27–29). Binding occurs at specific
RcsB consensus sites (30, 31), and the location of binding relative
to the 35 consensus sequence can dictate whether RcsB posi-
tively or negatively affects transcription (32). Tobe et al. (21) dem-
onstrated that upregulation of the LEE effector EspB in response
to rcsB overexpression also required the transcriptional regulator
GrvA (for global regulator of virulence A). Furthermore, the over-
expression of grvAwas shown to activate transcription from the ler
promoter (LEE1 operon) and to increase adherence to Caco-2
cells in vitro. In a subsequent study by Morgan et al. (20), both rcsB
and grvA were shown to be required for bicarbonate induction of
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the LEE. Collectively, these two studies reveal GrvA to be an acti-
vator of Ler that can interact with RcsB to communicate the bi-
carbonate signal to the LEE colonizing mechanism.
How RcsB controls grvA and how GrvA, in turn, controls LEE
expression are not known. GrvA shares homology with ToxR-
family protein regulators, such as MarT in Salmonella enterica
(30% amino acid identity) and CadC in E. coli (13% amino acid
identity). Both MarT and CadC are transcriptional activators,
with the latter activating the cadBA operon by displacing H-NS-
mediated repression (33). The similarity of GrvA to MarT and
CadC largely resides in the N terminus, containing a conserved
DNA-binding helix-turn-helix domain (COG3710) and a CheY-
like response regulator receiver domain (COG0745). In this study,
details of the molecular basis for grvA regulation and for GrvA-
dependent control of the LEE and LEE-dependent adherence are
determined. Furthermore, global RNA sequencing analysis signif-
icantly broadens our knowledge of the role for GrvA in regulation
to include genes central to acid resistance and metabolic fitness.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The strains and plasmids used
in this study are listed in Table 1. Strains were stocked at80°C in glycerol
diluted (final concentration, 15%, vol/vol) in Luria broth (LB) and were
maintained in LB or on LB with 1.5% agar (LBA). Unless otherwise noted,
overnight (18- to 20-h) cultures grown in LB were used to inoculate fresh
LB or LB buffered with sodium bicarbonate (44 mM NaHCO3) or fresh
Dulbecco’s modified Eagle’s medium (DMEM; 4 g/liter glucose, 4 mM
glutamine, 44 mM NaHCO3, pH 7.4) to a final optical density at 600 nm
(OD600) of 0.05. Cultures were grown at 37°C in a rotary shaker (200 rpm)
using a 1:10 medium-to-flask volume. Antibiotics (Sigma-Aldrich) were
added to the cultures when required.
Genetic manipulations and complementation. Primers used for ge-
netic manipulation and complementation are available upon request. For
construction of deletion mutants, the bacteriophage  Red-assisted one-
step deletion method adapted for EHEC was used as described previously
(20, 34, 35). Complementation of rcsBwas performed using vector pRJM-
20, as previously described (20). Additionally, a fragment containing the
entire rcsDB operon, including the rcsD promoter region (nucleotide po-
sitions 3041665 to 3046191; GenBank accession number NC_013008.1),
was cloned into BamHI/XbaI-digested low-copy-number expression vec-
tor pMPM-K3 (Kanr) (36) using primers RcsB3732/BamHI and
RcsB794/XbaI to produce pRJM-21. To complement grvA, a PCR prod-
uct corresponding to the grvA open reading frame (ORF) and including a
267-bp upstream region of grvA containing the predicted promoter (nu-
cleotide positions 1281984 to 1283134; GenBank accession number
NC_013008.1) was produced using primers GrvA268/XhoI and
GrvA884/BamHI and cloned into XhoI/BamHI-digested low-copy-
number expression vector pMPM-A2 (Ampr), creating pRJM-22. To
complement gadE, a PCR product corresponding to the gadE ORF and
762 bp of the sequence upstream of gadE (containing the native promot-
ers, nucleotide positions 4458857 to 4460195) was produced using prim-
ers GadE763/XbaI and GadE577/BamHI and cloned into the XbaI/
BamHI-digested vector pMPM-A2 to create pRJM-30. Confirmation of
genetic constructs was done using a combination of restriction mapping
and DNA sequencing (MWG Operon).
RNA purification and qRT-PCR. The primers used for quantitative
real-time PCR (qRT-PCR) are available upon request. RNA purification,
cDNA synthesis, qRT-PCR cycling conditions, and data analysis followed
previously described protocols (37) using a Realplex2 Mastercycler in-
strument (Eppendorf). Cycle threshold (CT) data were normalized to the
level of rrsH (16S rRNA gene) expression, and normalized cycle threshold
(CT) values were transformed to arbitrary transcript expression levels
using 2CT/106, as described previously (38, 39). Expression levels were
compared statistically by the appropriate t test or by Tukey’s honestly
significant difference (HSD) test following a significant F test (n 3, 
0.05; R software, version 3.1.0).
Construction of a single-copy grvAB-luxE operon fusion. A strain
containing a single-copy chromosome-plasmid luxE reporter fusion was
constructed using a protocol adapted from that of Shimizu et al. (40). To
make a grvAB-luxE fusion, the kan cassette and flanking FLP recombina-
tion target sites were amplified from pKD4 (34) using primers
pKD4forward/SacI and pKD4reverse/BamHI. This product was SacI/
BamHI digested and cloned into the BamHI/SacI site of pMPM-T3 to
produce pMPM-T3-kan. A XhoI/BamHI-digested PCR product contain-
ing the luxE gene and native ribosome binding site was amplified from
placlux8 (40) using primers LuxE-18/XhoI and LuxE1,450/BamHI
and cloned into the XhoI/BamHI site of similarly digested pMPM-T3-
kan to create pMPM-T3-luxE-kan. The luxE-kan PCR product ampli-
fied from pMPM-T3-luxE-kan using primers GrvA1,283/LuxE and
GrvA1,431/P2 and Phusion high-fidelity DNA polymerase (NEB)
was fused to a region 13 bp downstream of the grvAB operon using
bacteriophage  Red recombination (34). Kanamycin resistance cas-
settes were removed using FLP recombinase as described previously
(34), and the grvAB-luxE construct was validated using a combination
of restriction mapping and DNA sequencing (MWG Operon). The lux
operon genes luxCDAB were constitutively expressed in trans in
TW14359 grvAB-luxE from pluxCDAB3 (40, 41).
Luciferase activity. Overnight cultures grown in LB and DMEM were
used to inoculate fresh LB or DMEM, respectively, to an initial OD600 of
0.05. To measure the effect of sodium bicarbonate (NaHCO3) on grvA
expression, LB test cultures were grown with and without addition of 44
mM NaHCO3 (all DMEM cultures contained 44 mM NaHCO3). Cultures
(0.2 ml) were inoculated into 96-well, clear-bottom white-walled plates
(catalog number 655098; Greiner Bio-One) and incubated at 37°C in a
rotary shaker (200 rpm). Luciferase and OD600 measurements were taken
every hour for 10 h using a BioTek Synergy 2 plate reader (1 s integration)
prewarmed to 37°C. Mean luciferase activity was compared between treat-
ments (medium and NaHCO3 effects) using the appropriate t test (n 4,
  0.05; R software, version 3.1.0).
EMSAs. Electrophoretic mobility shift assays (EMSAs) were per-
formed as previously described (42). Briefly, the forward primers
RcsB4/NcoI and RcsB682/XhoI, used to PCR amplify rcsB from
TW14359 DNA, contained a new start codon and an N-terminal 6His
epitope tag, and the PCR product was cloned into the NcoI/XhoI sites of
similarly digested vector pET-24d to create pRJM-27. N-terminal 6His-
RcsB fusion proteins have wild-type RcsB activity (43). 6His-RcsB was
purified from strain BL21(DE3)pLysS using Ni-nitrilotriacetic acid spin
columns (Qiagen) according to the manufacturer’s protocol. Briefly,
overnight LB cultures containing 1 mM IPTG (isopropyl-	-D-thiogalac-
topyranoside) and kanamycin (50 
g/ml) grown at 18°C (200 rpm) were
pelleted and resuspended in 1.5 ml of lysis buffer (10 mM imidazole, 300
mM NaCl, 50 mM NaH2PO4, pH 8.0) and lysed by sonication for 3 min
(50% amplitude, 10-s intervals, 30-s pause) while they were chilled on ice.
The lysate was centrifuged at 21,000  g to remove insoluble cellular
debris, and the supernatant was used for column purification and subse-
quently eluted with elution buffer (500 mM imidazole, 300 mM NaCl, 50
mM NaH2PO4, pH 8.0). Purified 6His-RcsB protein was quantified
using a Bradford protein assay. Five prime biotin-labeled primers (Inte-
grated DNA Technologies oligonucleotides) were used to generate a
probe containing the grvA promoter (grvAP) region, including putative
RcsB consensus binding sites (Frag-2F and Frag-2R) (Fig. 1B). An addi-
tional upstream grvA promoter probe with no predicted RcsB consensus
sequence was amplified for use as a negative control (Frag-1F and Frag-
1R) (Fig. 1B). Biotin-labeled probes were gel purified using QIAquick gel
extraction kits (Qiagen) and diluted to a concentration of 0.5 ng/
l. All
EMSAs were performed using a LightShift chemiluminescent EMSA kit
(Thermo Pierce) according to the manufacturer’s specifications. Prior to
electrophoresis, purified 6His-RcsB and biotin-labeled fragments were
coincubated for 40 min in binding buffer (1 binding buffer, 50 ng/
l
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TABLE 1 Strains and plasmids used in this study
Strain or plasmid Relevant characteristics Reference or source
Strains
DH5 Vector propagation, recA1 endA1
BL21(DE3)pLysS BL21 with IPTG-inducible T7 polymerase 90
TW14359 Wild-type strain from the 2006 outbreak, western USA 91
EcRJM-1 TW14359 escN 20
EcRJM-6 TW14359 rcsB 20
EcRJM-10 TW14359 rcsB-FLAG 20
EcRJM-11 TW14359 grvA 20
EcRJM-12 TW14359 rcsB grvA 20
EcRJM-13 TW14359 tir-FLAG 20
EcRJM-35 TW14359 grlR::kan 20
EcRJM-72 TW14359 rcsB/pRJM-20 20
EcRJM-73 TW14359 lacZ This study
EcRJM-74 TW14359/pRJM-23 This study
EcRJM-75 TW14359/pRJM-24 This study
EcRJM-76 TW14359/pRJM-25 This study
EcRJM-77 TW14359/pRJM-26 This study
EcRJM-78 TW14359 grvA/pRJM-23 This study
EcRJM-79 TW14359 grvA/pRJM-24 This study
EcRJM-80 TW14359 grvA/pRJM-25 This study
EcRJM-81 TW14359 grvA/pRJM-26 This study
EcRJM-82 TW14359 grvA gadE::kan/pRJM-24 This study
EcRJM-110 TW14359 grvA gadE::kan/pRJM-26 This study
EcRJM-83 TW14359 grvA/pRJM-22 This study
EcRJM-84 TW14359 rcsB grvA/pRJM-22 This study
EcRJM-85 TW14359 rcsB grvA/pRJM-20 This study
EcRJM-86 TW14359 rcsDB-luxE This study
EcRJM-87 TW14359 grvAB-luxE This study
EcRJM-88 TW14359 rcsDB-luxE/pluxCDAB3 This study
EcRJM-89 TW14359 grvAB-luxE/pluxCDAB3 This study
EcRJM-90 TW14359 gadE::kan This study
EcRJM-91 TW14359 grvA gadE::kan This study
EcRJM-92 TW14359 gadE::kan/pRJM-30 This study
EcRJM-93 TW14359 grvA gadE::kan/pRJM-30 This study
EcRJM-94 TW14359 zinT-FLAG::kan This study
EcRJM-95 TW14359 grvA zinT-FLAG::kan This study
EcRJM-96 TW14359/pRJM-31 This study
EcRJM-97 EPECa E2348/69/pRJM-31 This study
EcRJM-98 MG1655/pRJM-31 This study
EcRJM-99 DH5/pRJM-31 This study
EcRJM-100 TW14359/pRJM-32 This study
EcRJM-101 EPEC E2348/69/pRJM-32 This study
EcRJM-102 MG1655/pRJM-32 This study
EcRJM-103 DH5/pRJM-32 This study
EcRJM-104 TW14359 rcsDB-luxE/pluxCDAB3/pRJM-21 This study
EcRJM-105 TW14359 grvAB-luxE/pluxCDAB3/pRJM-21 This study
EcRJM-106 TW14359 grvA/pRJM-23 This study
EcRJM-107 TW14359 grvA/pRJM-24 This study
EcRJM-108 TW14359 grvA/pRJM-25 This study
EcRJM-109 TW14359 grvA/pRJM-26 This study
Plasmids
pACYC177 Low-copy-no. cloning vector, Ampr Kanr P15A
pBAD22 Ara-inducible expression vector, Ampr M13 92
pMPM-A2 Low-copy-no. cloning vector, Ampr pMB1/f1 36
pMPM-K3 Low-copy-no. cloning vector, Kanr p15A/f1 36
pMPM-T3 Low-copy-no. cloning vector, Tetr p15A/f1 36
pUC19 High-copy-no. cloning vector, Ampr pMB1 93
pRS551 lac fusion vector, Ampr Kanr lacZ ColE1
pCP20 FLP recombinase expression vector 34
pKD4 Template plasmid for Kan cassette 34
pKM208 Bacteriophage  Red recombinase expression vector 34
(Continued on following page)
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sheared salmon sperm DNA, 2.5% glycerol, 0.05% NP-40, 5 mM MgCl2,
50 mM KCl, 1 mM EDTA) at room temperature. Samples were loaded
into a prerun and cooled 8% native polyacrylamide gel and run at 20 V/cm
for 1 h. Following electrophoresis, biotin-labeled DNA was transferred
(25 V for 20 min) to a Biodyne B precut modified nylon membrane
(Thermo Pierce) and UV cross-linked for 60 s. Biotin-labeled DNA frag-
ments were detected using streptavidin-horseradish peroxidase-conju-
gated antibodies (1:300) in blocking buffer, and the membranes were
washed, equilibrated, and subsequently detected using luminol/enhancer
solutions in a ChemiDoc XRS imaging system and Image Lab (version
3.0) software (Bio-Rad).
Construction of lacZ transcriptional fusions and -galactosidase
assays. Construction of a grvAP-lacZ reporter transcriptional fusion fol-
lowed a previously described protocol using pRS551 (Table 1) (20).
Briefly, a 306-bp PCR product containing the predicted grvA promoter
was amplified from TW14359 genomic DNA using primers GrvA268/
EcoRI and GrvA38/BamHI, BamHI/EcoRI digested, and then cloned
into similarly digested pRS551, resulting in pRJM-31. Four different
gadEP-lacZ promoter fusions were created by cloning BamHI/EcoRI-di-
gested PCR products into similarly digested pRS551 using primers
GadE320/EcoRI and GadE1/BamHI, GadE276/EcoRI and
GadE516/BamHI, GadE773/EcoRI and GadE497/BamHI, and
GadE773/EcoRI and GadE1/BamHI. 	-Galactosidase activity (Miller
units) was measured as previously described (38, 44), and the numbers of
Miller units were compared using the appropriate t test or by Tukey’s HSD
test following a significant F test (n  3,   0.05; R software, version
3.1.0).
RNA sequencing and data analysis. RNA extractions were performed
as described above for qRT-PCR, except that residual genomic DNA was
digested using Turbo DNase (catalog number AM2238; Ambion) follow-
ing the manufacturer’s protocol. Three independent RNA samples for
each strain (TW14359 and TW14359 grvA) were pooled into a single
sample (n 1) in a 1:1:1 ratio to account for intersample variability, and
rRNA was removed using a MICROBExpress bacterial mRNA enrich-
ment kit (catalog number AM1905; Ambion) according to the manufac-
turer’s instructions. The integrity and concentration of purified and en-
riched mRNA were determined using an Agilent 2100 bioanalyzer
(Agilent Technologies). RNA sequencing (RNA-seq) was performed as
previously described (45). Briefly, mRNA was converted to strand-spe-
cific cDNA using an Ion Total RNA-Seq kit (version 2; catalog number
4475936; Ion Torrent), and samples were sequenced using an Ion Per-
sonal Genome Machine (PGM) system (Ion Torrent). Sequence mapping
and data analysis were performed using CLC Genomics Workbench (ver-
sion 6) software (CLC Bio). Subsequent reads per kilobase per million
mapped reads (RPKM) values were converted to the fold change for
TW14359 grvA relative to the value for wild-type strain TW14359. Cir-
cular plots were created using Circos (version 0.65) software (http://www
.circos.ca) (46).
Intestinal cell adherence assays. The maintenance and culture of
HT-29 colonic intestinal cells were performed as previously described
(20). Adherence competition indexes were determined using the method
of Gabbianelli et al. (47). Briefly, overnight DMEM cultures were used to
inoculate fresh DMEM to an OD600 of 0.05, and these were then incubated
for 3 h at 37°C with shaking (200 rpm). Cultures were then diluted to an
OD600 of 0.5 and mixed in a 1:1 ratio (test strain/control strain), and 0.2
ml of each was used to inoculate HT-29 cells in 6-well culture plates. A
control strain incapable of utilizing lactose (a Lac strain) was con-
structed by deleting the entire lacZ ORF in TW14359 (strain EcRJM-73)
using the bacteriophageRed approach and deletion primers LacZ1/P1
and LacZ3115/P2 (primer sequences are available upon request). Each
plate was gently mixed before centrifugation at 500 g for 5 min and then
incubated as described above. Following 3 h of incubation, each well was
washed four times using sterile phosphate-buffered saline (PBS) to re-
move nonadherent cells, and adherent cells were removed using 500
l of
0.1% Triton X-100. Cells were enumerated (number of CFU per millili-
ter) by serial dilution in PBS and plating onto MacConkey agar, which is
differential for lactose utilization. After overnight growth on MacConkey
agar, pink (Lac-positive [Lac]) colonies were scored as the numbers of
CFU per milliliter for the test strain, whereas white (Lac-negative [Lac])
colonies were scored as the numbers of CFU per milliliter for strain
TW14359lacZ. The competitive index was derived by dividing the num-
bers of CFU per milliliter of the test strain by the numbers of CFU per
milliliter of TW14359 lacZ, and the indexes were compared statistically
using the appropriate t test (n 3,   0.05; R software, version 3.1.0).
Test for acid resistance. Acid resistance by the glutamate-dependent
system was measured as described previously (37) with slight adaptations.
Mid-exponential-phase (OD600  0.5) DMEM cultures were inoculated
to a 106-CFU/ml final cell density in E minimal glucose (EG) medium
with or without 5.7 mM L-glutamate at pH 7 (control) or acidified with
HCl (pH 2). For cell count (number of CFU per milliliter) and percent
survival determinations, samples were serially diluted in PBS (pH 7),
plated onto LBA, and incubated overnight at 37°C.
TABLE 1 (Continued)
Strain or plasmid Relevant characteristics Reference or source
pET-24d T7 promoter, His tag vector, Kanr f1, pBR322 Novagen
pSU312 FLAG epitope template, Ampr Kanr, R6K 94
pRJM-20 pACYC177-rcsB 20
pRJM-33 pACYC177-grvAB This study
pRJM-21 pMPM-K3-rcsDB This study
pRJM-22 pMPM-A2-grvA This study
pRJM-23 pRS551-gadEP(773,1)
b This study
pRJM-24 pRS551-gadEP(320,1) This study
pRJM-25 pRS551-gadEP(516,276) This study
pRJM-26 pRS551-gadEP(773,497) This study
pRJM-27 pET-24d-6His-rcsB This study
pRJM-28 pMPM-T3-kan This study
pRJM-29 pMPM-T3-luxE-kan This study
pRJM-30 pMPM-A2-gadE This study
pRJM-31 pRS551-grvAP(268,38) This study
pRJM-32 pUC-grvA-6His This study
placlux8 placlux8 40
pLuxCDAB3 pLuxCDAB3 40
a EPEC, enteropathogenic E. coli.
b The numbers indicate the positions in gadEP.
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RESULTS
Transcription of grvA is growth phase dependent and directly
activated by RcsB. Previous work has shown the response regula-
tor of the rcs phosphorelay system RcsB to be an activator of global
regulator of virulence A (grvA) and both factors to be required for
full bicarbonate induction of the LEE-encoded regulator Ler and
subsequent stimulation of LEE expression in EHEC during expo-
nential-phase growth (20, 21). RcsB is predicted to act upstream of
grvA in the regulation of ler, yet the mechanism underlying the
control of grvA by RcsB is unknown.
The level of transcription of grvA in reporter strain TW14359
grvAB-luxE⁄pluxCDAB3 (EcRJM-89) (Table 1) grown in DMEM
with sodium bicarbonate (44 mM) was the highest during early
exponential-phase growth, rapidly declining as cultures transi-
tioned into postexponential phase (Fig. 1A). When grown in LB,
the level of grvA transcription was similar to that observed when
grown in DMEM; however, the levels were consistently lower over
the first 7 h. Addition of sodium bicarbonate (44 mM) to LB,
previously shown to upregulate RcsB levels (20), had no signifi-
cant impact on grvA transcription, while overexpression of rcsDB
in trans in TW14359 grvAB-luxE⁄pluxCDAB3 substantially in-
creased the level of grvA transcription when grown on LB agar in
the absence of sodium bicarbonate (Fig. 1A). Thus, the addition of
bicarbonate alone is not sufficient for upregulation of grvA. That
overexpression of rcsB increased the level of transcription from
the grvA promoter suggests that RcsB may directly activate grvA
transcription. In support of this, two putative tandem RcsB bind-
ing sites proximal to a predicted35 site (nucleotides 1282968 to
1282982 in TW14359) of the grvA promoter (grvAP) have been
described previously (21, 31) (Fig. 1B, Box 1 and Box 2). To test
for interactions between RcsB and the grvA promoter, purified
6His-tagged RcsB was coincubated with a fragment of the core
grvABP element, including putative RcsB binding sites (Fig. 1B,
Frag-2) and analyzed using electrophoretic mobility shift assays.
As anticipated, the 235-bp grvABP fragment was visibly shifted
with the addition of increasing amounts (1 to 12 
g) of 6His-
RcsB, while no shift was observed for the control fragment (Fig.
1B, Frag-1, and C). These findings suggest that RcsB is a direct
transcriptional activator of grvA and that activation occurs at the
grvA core promoter region containing at least one putative RcsB
binding site.
GrvA is a regulatorofpathogenicmechanismsandmetabolic
fitness in EHEC. grvA is required for LEE activation by the Rcs
phosphorelay system in EHEC (21). How, in turn, GrvA upregu-
lates LEE expression and the scope of genes under the control of
GrvA are unknown. To explore this, the transcriptomes of EHEC
FIG 1 Rcs response regulator RcsB directly activates transcription from the grvAB promoter. (A) (Left) Average luciferase activity (in relative light units [RLU])
plotted as a function of time for a single-copy grvAB-luxE fusion grown in DMEM, LB, or LB supplemented with 44 mM NaHCO3. Asterisks denote significance
by Student’s t test (*, P 0.05; **, P 0.01; n 3). Plots at each time point did not vary from the mean by more than 5%. (Right) Growth and grvAB promoter
expression (luciferase activity) (bottom) on LB agar plates for strain TW14359 grvAB-luxE/pluxCDAB3 transformed with empty vector pMPM-K3 (left) or
pMPM::rcsDB (right). (B) (Left) Map of the grvAB promoter and flanking regions in strain TW14359. Fragments for EMSA (Frag-1 and Frag-2) and the
respective primers for probe generation are indicated. Frag-1 is the negative control; Frag-2 contains two putative RcsB binding sites (Box 1 and Box 2). (Right)
Alignment of box 1 from the grvAB promoter with experimentally proven RcsB homodimer boxes for rprA and osmC promoters. Conserved bases are in bold and
underlined. (C) EMSA for RcsB binding to Frag-2 of the grvAB promoter. The wedge denotes the increasing amount of RcsB added (1 to 12 
g). For Frag-1
(control), RcsB was added at 0 
g (lane) and 12 
g (lane).
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O157:H7 strain TW14359 and its grvA isogenic derivative
(TW14359 grvA) were measured by RNA-seq analysis during
exponential-phase growth (OD600  0.5) in LEE-inducing me-
dium (DMEM).
In TW14359 grvA, 765 genes were altered in expression2-
fold above the RPKM cutoff compared to their expression in
TW14359; of these, 264 were upregulated and 501 were down-
regulated (Fig. 2; unpublished data). Known virulence-associated
FIG 2 The GrvA regulon in EHEC strain TW14359. (A) Circular plot of RNA-seq data for EHEC strains TW14359 and TW14359 grvA. Nucleotide positions
are based on the TW14359 annotation (GenBank accession number NC_013008.1), indicated by the black outer ring. The heat map denotes the fold change in
RPKM for TW14359grvA relative to the level of expression in TW14359 for each gene. The two inner histograms indicate the RPKM values of TW14359 (black)
and TW14359 grvA (red). Plots were generated using Circos (version 0.65; http://www.circos.ca). (B) Number of genes in grvA whose expression is altered
relative to their expression in TW14359 plotted for each ontological group. The levels of expression of a total of 765 genes were altered by2-fold; upregulation
and downregulation are indicated.
GrvA-Dependent Regulation of EHEC Pathogenesis
February 2016 Volume 198 Number 3 jb.asm.org 399Journal of Bacteriology
 o
n
 July 9, 2018 by Univ of South Florida
http://jb.asm.org/
D
ow
nloaded from
 
genes made up 6% of the genes whose expression was altered (8
upregulated, 38 downregulated). The majority of these were LEE-
encoded structural proteins and secreted effectors, consistent with
the role of GrvA as a positive regulator of LEE expression (Fig. 2A
and B). Twenty-one LEE genes were downregulated in TW14359
grvA, including the LEE-encoded regulator ler, type III secretion
translocon genes espA, espB, espD, and eaeA (encoding intimin),
and the secreted effector tir (translocated intimin receptor) (Table
2). Five non-LEE-encoded effectors (nleC, nleA, nleH2, nleF, and
nleE) were also downregulated in TW14359 grvA. Genes en-
coded within the 15-kb genomic acid fitness island (AFI), the
products of which are required for survival at low pH (48), were
upregulated in TW14359 grvA compared to their level of regu-
lation in TW14359, in which the expression of AFI genes was
barely detectable (Table 2). Most notably, genes of the glutamate-
dependent acid resistance (GDAR) system were upregulated, in-
cluding gadA, gadE, gadW, gadX, and the non-AFI-encoded
gadCB operon. Thus, GrvA activates the LEE colonization mech-
anism while repressing acid resistance systems.
Twenty-six percent of the genes whose expression was altered
(57 upregulated, 140 downregulated) had defined metabolic func-
tions, suggesting a broader role for GrvA in regulation and fitness
(Fig. 2B). This included genes for asparagine synthesis (asnA,
asnB) and arginine degradation (ast operon) (Table 2). Nine per-
cent (23 upregulated, 45 downregulated) were known or pre-
dicted regulators, and of these, global nitrogen metabolism regu-
lators ntrC (also glnG) and nac, as well as cbl for sulfonate
utilization, were downregulated. Eight percent (18 upregulated,
42 downregulated) were transport systems, and of these, gluta-
mate (glt operon), glutamine (gln operon, and ammonium
(amtB) transporters were downregulated. Thirty-seven percent
(112 upregulated, 171 downregulated) had unknown or hypo-
thetical functions (Table 2). Genes for zinc binding and transport,
as well as resistance to zinc and other metals, were upregulated in
TW14359 grvA, including znuA, znuCB, zinT (formerly yodA),
rpmE2, rpmJ, ykgL, and yebA (49–51).
Alterations in the expression of astC (arginine metabolism), ler
(LEE regulator), gadE (acid resistance), and znuC (zinc transport)
were validated by qRT-PCR. Complementation of grvA in trans
(strain TW14359grvA/pgrvA) largely restored wild-type expres-
sion for ler and znuA but only partially restored expression for
gadE and astC (Table 3). Deletion of rcsB in TW14359 grvA had
no further significant impact on the expression of ler or any other
targets tested (Table 3).
GrvA requires acid resistance regulator gadE for control of
ler and adherence to intestinal cells. RNA-seq analysis revealed
that deletion of grvA leads to the upregulation of gadE, a known
transcriptional repressor of LEE-encoded regulator ler (52, 53). As
such, the contribution of gadE to GrvA-dependent control of the
LEE and adherence to cultured intestinal epithelial cells was ex-
amined.
During exponential-phase growth, gadE transcription is
strongly repressed (54, 55). As such, the level of expression of ler in
TW14359 gadE only marginally increased compared to that in
TW14359 (Fig. 3A). However, when gadE was constitutively ex-
pressed in both TW14359 grvA and TW14359 grvA gadE, ler
expression was reduced to the level of that observed in TW14359
grvA (Fig. 3A) (P 0.05).
The effect of the grvA and gadE interaction on in vitro adher-
ence was determined using a competition assay. Strains were co-
incubated in a 1:1 ratio with HT-29 intestinal cells, followed by
plating and enumeration on MacConkey differential medium. For
a control strain, lacZ was deleted from wild-type strain TW14359,
and thus, the strain was Lac and colonies on MacConkey agar
were white, whereas the test strains (TW14359 and genetic deriv-
atives) were Lac, producing pink colonies. For each test strain, an
adherence index was determined from plate counts as the ratio of
the number of CFU per milliliter for the test strain relative to the
number of CFU per milliliter for the Lac wild-type control
strain.
In agreement with the ler expression data (Fig. 3A), the adher-
ence index of TW14359 grvA was significantly decreased com-
pared to the adherence indexes of the wild type, TW14359gadE,
TW14359 grvA gadE, and grvA-complemented strain
TW14359 grvA/pgrvA (P  0.05) but not that of type III secre-
tion-defective strain TW14359 escN (Fig. 3B). In strains where
gadE was expressed constitutively, the adherence index was uni-
formly reduced to levels lower than those in all other strains, in-
cluding TW14359 escN (P  0.001), suggesting that GadE may
impact adherence in both a LEE-dependent and a LEE-indepen-
dent manner (Fig. 3B). Only in strain TW14359 grlR::kan, in
which the LEE is overexpressed (20), was the adherence index
increased. The results of these experiments are consistent with the
hypothesis that control of the LEE and adherence by GrvA are
directed through the repression of gadE.
Negative regulation of gadEbyGrvA requiresGadW.GadE is
a negative regulator of LEE expression, acting directly on the LEE1
promoter to repress ler transcription (52, 53). In the preceding
experiments, the upregulation of ler by GrvA was determined to
correspond with gadE repression. Three discrete promoters have
been shown to control transcription of the gadE gene in E. coli
K-12 MG1655 (56). To better understand the molecular basis
underlying the regulation of gadE promoters P1 to P3 by GrvA,
the levels of transcription from four different gadE lacZ re-
porter constructs in TW14359 and TW14359 grvA were com-
pared during exponential-phase and stationary-phase growth
in DMEM (Fig. 4A).
During exponential-phase growth, the level of transcription
from gadE-lacZ containing all three gadE promoters (P1 through
P3; Frag-1) was significantly increased in TW14359 grvA com-
pared to that in TW14359 (P  0.01) (Fig. 4A) (55). Promoter
activity from fragments containing the P1 or P3 promoter alone
(Frag-2 and Frag-4, respectively) was also significantly higher in
TW14359 grvA (P  0.05), while activity from the fragment
containing only the P2 promoter (Frag-3) did not differ between
TW14359grvA and TW14359. As anticipated, promoter activity
from all fragments increased significantly during stationary-phase
growth for TW14359 (P  0.01) yet increased only slightly from
P2 (P  0.05). For TW14359 grvA, promoter activity further
increased only from P1 during stationary phase (P  0.01) and
was higher than the activity from P1 in TW14359 (Fig. 4A). This
was predicted to be due to autoactivation of the P1 promoter by
GadE (54), as deletion of gadE in TW14359 grvA eliminated P1
activation (Frag-2) during exponential-phase growth but had no
effect on P3 activity (Frag-4) (Fig. 4B). On the basis of these find-
ings, it is suspected that the GrvA-dependent regulation of gadE
transcription is directed solely through the P3 promoter.
Transcription from the gadEP3 promoter is directly controlled
by the AFI-encoded regulators GadX and GadW (56), and RNA-
seq analysis of TW14359grvA revealed the levels of expression of
Morgan et al.
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TABLE 2 RNA-seq GrvA transcriptome
Gene identifiera
Gene
name
Fold change in
grvA mutantb
RPKMc
Gene product descriptionWild type grvA mutant
LEE pathogenicity island genes and genes
for non-LEE-encoded effectors
ECSP_4665 espF 3.1 16.5 5.4 LEE-encoded effector
ECSP_4666 orf29 3.4 11.9 3.5 LEE-encoded protein
ECSP_4667 escF 5.8 15.5 2.7 LEE-encoded protein
ECSP_4668 cesD2 8.3 46.3 5.6 Predicted chaperone
ECSP_4669 espB 6.6 658.8 100.5 Secreted protein EspB
ECSP_4670 espD 4.5 208.3 46.4 Secreted protein EspD
ECSP_4671 espA 4.4 165.3 37.7 Secreted protein EspA
ECSP_4672 sepL 4.5 46.8 10.3 LEE-encoded T3S component
ECSP_4673 escD 4.0 4.8 1.2 LEE-encoded T3S component
ECSP_4674 eaeA 4.8 75.0 15.8 Intimin adherence protein
ECSP_4675 cesT 5.9 105.0 17.7 Chaperone
ECSP_4676 tir 4.0 186.7 46.6 Translocated intimin receptor
ECSP_4677 map 4.4 27.7 6.3 LEE-encoded effector
ECSP_4678 cesF ND ()d 3.4 104 Chaperone
ECSP_4679 espH 4.8 22.9 4.8 LEE-encoded effector
ECSP_4680 escQ 1.9 9.7 5.0 LEE-encoded protein
ECSP_4681 orf16 8.1 14.7 1.8 LEE-encoded protein
ECSP_4682 orf15 1.2 5.9 4.9 LEE-encoded protein
ECSP_4683 escN 2.7 16.8 6.2 LEE-encoded ATPase
ECSP_4684 escV 2.3 11.6 5.1 LEE-encoded protein
ECSP_4685 orf12 1.3 2.6 2.0 LEE-encoded protein
ECSP_4686 espZ 3.5 78.4 22.6 LEE-encoded effector
ECSP_4687 escI 1.3 12.7 9.9 LEE-encoded protein
ECSP_4688 escJ 2.8 18.4 6.6 LEE-encoded protein
ECSP_4689 sepD 1.3 2.2 1.7 LEE-encoded protein
ECSP_4690 escC 1.7 7.8 4.5 T3S needle complex subunit
ECSP_4691 cesD 1.1 6.5 6.0 LEE-encoded protein
ECSP_4692 grlA 1.1 15.3 13.8 Global regulator of LEE, activator
ECSP_4693 grlR 1.9 11.4 5.9 Global regulator of LEE, repressor
ECSP_4694 etgA 1.5 1.3 0.9 Lytic transglycosylase
ECSP_4695 escU ND () 1.6 104 LEE-encoded protein
ECSP_4696 escT ND () 2.0 104 LEE-encoded protein
ECSP_4697 escS 4.0 0.6 2.4 LEE-encoded protein
ECSP_4698 escR 1.6 4.3 2.6 LEE-encoded protein
ECSP_4699 escL 2.9 12.2 4.2 LEE-encoded protein
ECSP_4700 orf4 1.8 10.3 5.6 LEE-encoded protein
ECSP_4701 cesA 1.0 2.2 2.2 Chaperone
ECSP_4702 escE 1.1 18.3 16.2 LEE-encoded protein
ECSP_4703 ler 2.5 55.7 22.7 LEE encoded regulator
ECSP_4704 espG 3.7 4.5 1.2 LEE encoded effector
ECSP_4705 rorf1 1.0 0.6 0.6 LEE-encoded protein
ECSP_0061 espY1 2.0 0.3 0.6 Non-LEE-encoded effector
ECSP_0866 nleC 2.3 4.3 1.9 Non-LEE-encoded effector
ECSP_0868 nleD 1.7 7.3 4.4 Non-LEE-encoded effector
ECSP_1702 nleA 4.0 1.5 0.4 Non-LEE-encoded effector
ECSP_1704 nleH2 2.2 3.8 8.6 Non-LEE-encoded effector
ECSP_1705 nleF 3.7 16.2 4.4 Non-LEE-encoded effector
ECSP_3954 nleE 4.0 2.6 0.6 Non-LEE-encoded effector
Metabolism and acid resistance genes
ECSP_0704 gltL 3.9 149.2 38.4 Glutamate and aspartate transporter
ECSP_0705 gltK 3.0 31.2 10.3 Glutamate and aspartate transporter
ECSP_0706 gltJ 2.5 29.9 12.0 Glutamate and aspartate transporter
ECSP_0707 gltI 3.0 156.1 52.4 Glutamate and aspartate transporter
ECSP_0906 glnQ 2.3 277.1 118.0 Glutamine transporter subunit
ECSP_0907 glnP 2.3 32.1 13.8 Glutamine transporter subunit
ECSP_0908 glnH 1.5 141.1 93.5 Glutamine transporter subunit
ECSP_1977 gadC 15.6 1.3 20.5 Glutamate:gamma-aminobutyric acid antiporter
(Continued on following page)
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TABLE 2 (Continued)
Gene identifiera
Gene
name
Fold change in
grvA mutantb
RPKMc
Gene product descriptionWild type grvA mutant
ECSP_1978 gadB 14.6 4.1 59.5 Glutamate decarboxylase B
ECSP_2312 astE 4.0 9.7 2.4 Succinylglutamate desuccinylase
ECSP_2313 astB 5.9 10.9 1.8 Succinylarginine dihydrolase
ECSP_2314 astD 9.1 18.3 2.0 Succinylglutamic semialdehyde dehydrogenase
ECSP_2315 astA ND () 25.5 104 Arginine succinyltransferase
ECSP_2316 astC 66.0 52.4 0.8 Succinylornithine transaminase
ECSP_2329 gdhA 1.8 53.4 23.0 Glutamate dehydrogenase
ECSP_3185 argT 3.5 89.1 25.3 Lysine/arginine/ornithine transporter subunit
ECSP_4065 uxaA 1.7 12.6 21.4 Altronate hydrolase
ECSP_4066 uxaC 1.8 7.8 13.6 Uronate isomerase
ECSP_4486 slp 2.0 37.4 74.3 Outer membrane lipoprotein
ECSP_4498 hdeB ND () 104 13.6 Acid resistance protein
ECSP_4499 hdeA ND () 104 134.4 Acid resistance protein
ECSP_4500 hdeD ND () 104 11.7 Acid resistance protein
ECSP_4501 gadE ND () 104 10.8 GDAR activator
ECSP_4502 mdtE ND () 104 11.6 Multidrug resistance efflux transporter
ECSP_4503 mdtF ND () 104 12.9 Multidrug resistance efflux transporter
ECSP_4504 gadW ND () 104 9.1 DNA-binding transcriptional activator
ECSP_4505 1.0 104 0.0 Hypothetical protein
ECSP_4506 gadX ND () 104 5.0 DNA-binding transcriptional dual regulator
ECSP_4507 gadA ND () 104 18.3 Glutamate decarboxylase A
ECSP_4508 yhjA 1.0 104 104 Cytochrome c peroxidase
ECSP_4509 treF ND () 104 3.4 Cytoplasmic trehalase
ECSP_4510 yhjB 1.0 104 104 DNA-binding response regulator
ECSP_4511 yhjC ND () 104 2.6 DNA-binding transcriptional regulator
ECSP_4512 yhjD ND () 104 5.1 Conserved inner membrane protein
ECSP_4513 yhjE 87.3 0.2 16.3 Predicted transporter
ECSP_4921 ND 2.7 104 Hypothetical protein
ECSP_4922 1.1 78.6 74.4 Hypothetical protein
ECSP_4923 glnG 3.7 83.9 22.4 DNA-binding response regulator
ECSP_4924 glnL 3.7 117.1 31.6 Sensory histidine kinase
ECSP_4925 glnA 4.3 745.3 172.4 Glutamine synthetase
ECSP_0518 glnK ND () 143.4 104 Nitrogen assimilation regulatory protein
ECSP_0519 amtB 74.8 185.6 2.7 Ammonium transporter
ECSP_4793 asnC 2.0 5.2 2.6 DNA-binding transcriptional regulator
ECSP_4794 asnA 5.0 2,647.6 532.5 Asparagine synthetase A
ECSP_0721 asnB 7.6 688.2 90.7 Asparagine synthetase B
ECSP_2651 cbl 4.8 14.1 2.9 DNA-binding transcriptional activator
ECSP_2652 nac 63.5 32.0 0.5 DNA-binding transcriptional dual regulator
ECSP_3790 galR 2.1 13.2 6.4 DNA-binding transcriptional repressor
ECSP_3791 lysA 4.3 23.1 5.4 Diaminopimelate decarboxylase
ECSP_3792 lysR 2.8 2.8 1.0 DNA-binding transcriptional dual regulator
Metal stress response and
import/export genes
ECSP_0334 ykgL ND () 104 1.4 Predicted protein
ECSP_0335 rpmJ 170.7 1.7 284.6 50S ribosomal protein L36
ECSP_0336 rpmE2 565.7 0.6 346.5 Zn(II)-responsive ribosomal protein
ECSP_0622 cusS 1.3 7.6 5.8 Sensory histidine kinase
ECSP_0623 cusR 1.1 36.3 38.9 DNA-binding response regulator
ECSP_0624 cusC 1.0 15.6 15.0 Copper/silver efflux system
ECSP_0625 cusF 1.8 47.5 26.5 Periplasmic copper-binding protein
ECSP_0626 cusB 1.3 111.6 82.8 Copper/silver efflux system
ECSP_0627 cusA 1.4 67.5 48.0 Copper/silver efflux system
ECSP_0731 fur 1.7 38.2 64.5 DNA-binding regulator
ECSP_2430 yebA 4.5 17.0 75.9 Predicted peptidase
ECSP_2431 znuA 17.7 13.8 244.0 High-affinity zinc uptake system
ECSP_2432 znuC 2.5 4.5 18.9 High-affinity zinc uptake system
ECSP_2433 znuB 4.2 4.6 11.4 High-affinity zinc uptake system
(Continued on following page)
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both genes to be elevated compared to their levels of expression in
TW14359 (Table 2). It was thus predicted that repression of P3 by
GrvA was mediated through one or both of these regulators. To
test this, the effect of gadX and gadW deletion in TW14359 grvA
on P3 activity during exponential-phase growth (OD600 0.5) in
DMEM was measured. Only the deletion of gadW was observed to
reduce the level of transcription from P3 (Fig. 4C). Activity from
P3 in TW14359gadW and TW14359grvAgadW was reduced
significantly compared to that in TW14359 grvA (P 0.01 and
0.03, respectively) but not compared to that in TW14359. Con-
versely, activity from P3 was slightly but significantly increased in
TW14359 grvA gadX compared to that in TW14359 grvA
(P 0.01) (Fig. 4C). Taken together, these data indicate that GrvA
indirectly represses transcription from the gadE P3 promoter dur-
ing exponential-phase growth in a manner that is dependent on
gadW.
GrvA is a novel repressor of glutamate-dependent acid resis-
tance. The transcription of GDAR genes is growth phase depen-
dent; expression is tightly controlled and low during exponential-
phase growth but increases markedly as cells transition into
stationary phase (57). Correspondingly, exponential-phase cul-
tures are generally acid susceptible, while stationary-phase cul-
tures are acid resistant. Since deletion of grvA was shown to up-
regulate GDAR genes (gadA, gadBC, gadE, gadW, gadX) during
exponential-phase growth, the contribution of GrvA to GDAR
was determined for exponential-phase cultures and was compared
to that of the GDAR phenotype of stationary-phase cultures. In
addition, since RcsB activates grvA transcription and is a dual
regulator of GDAR system genes in E. coli K-12 (28, 58, 59), the
interactions of rcsB and grvA in expression of the GDAR pheno-
type in EHEC O157:H7 were examined.
As expected, no colonies of wild-type TW14359 grown to
exponential phase could be recovered on LBA following a 1-h
challenge in acidified (pH 2) EG medium (Fig. 5, top). How-
ever, for strain TW14359 grvA, in which GDAR genes are
upregulated during exponential-phase growth, 400 CFU/ml,
corresponding to 9% of the original inoculum, was recovered.
Complementation of TW14359 grvA with grvA restored acid
sensitivity to wild-type levels. GDAR was abrogated following
deletion of rcsB in TW14359 grvA, and complementation
with rcsB restored GDAR in TW14359 grvA rcsB but not in
TW14359 rcsB.
In stationary phase, during which GDAR is actively expressed
(57), deletion and complementation of grvA had no effect on sur-
vival in acid, with 100% of the initial inoculum being recovered
following a 1-h challenge in acidified EG medium (Fig. 5, bottom).
TABLE 2 (Continued)
Gene identifiera
Gene
name
Fold change in
grvA mutantb
RPKMc
Gene product descriptionWild type grvA mutant
ECSP_2579 zinT 163.7 2.0 328.1 Conserved metal-binding protein
ECSP_4263 zntR 1.1 11.4 9.9 DNA-binding transcriptional activator
ECSP_4425 zntA 1.4 19.9 14.3 Zinc, cobalt, and lead efflux system
Genes for other functions
ECSP_1968 ddpF 1.1 2.3 2.5 D-Ala–D-Ala transporter subunit
ECSP_1969 ddpD 1.5 1.0 1.4 D-Ala–D-Ala transporter subunit
ECSP_1970 ddpC 1.6 1.3 2.1 D-Ala–D-Ala transporter subunit
ECSP_1971 ddpB 6.5 3.1 0.5 D-Ala–D-Ala transporter subunit
ECSP_1972 ddpA 28.7 9.3 0.3 D-Ala–D-Ala transporter subunit
ECSP_1973 ddpX ND () 7.3 104 D-Ala–D-Ala dipeptidase
ECSP_2574 yedV 1.8 2.7 1.4 Sensory kinase
ECSP_2575 yedW 1.0 48.2 26.5 DNA-binding regulator
ECSP_5434 yjiA 2.8 12.3 34.1 Predicted GTPase
ECSP_5435 yjiX 27.8 0.7 19.5 Conserved protein
ECSP_5436 yjiY 3.8 64.6 246.2 Predicted protein
ECSP_2492 2.4 1,462.1 620.0 Hypothetical protein
ECSP_4094 1.9 1,576.0 841.5 Hypothetical protein
a Based on EHEC O157:H7 strain TW14359 (GenBank accession number NC_013008.1).
b Fold change was calculated as the wild-type RPKM value divided by the mutant strain RPKM value.
c RPKM, reads per kilobase per million mapped reads.
d ND, not determined; (), upregulated; (), downregulated.
TABLE 3 qRT-PCR validation of RNA-seq data
Strain
Expression unitsa
ler gadE astC znuA
TW14359 1,054.77 (51.81) 0.18 (0.06) 111.56 (1.55) 8.02 (2.34)
grvA mutant 78.28 (21.68) 61.11 (8.22) 1.21 (0.67) 551.15 (150.90)
rcsB grvA mutant 127.97 (33.65) 87.87 (4.10) 2.5 (1.49) 622.03 (46.05)
grvA pgrvA mutant 556.98 (180.36) 12.94 (0.81) 6.87 (2.24) 20.46 (8.28)
a For each gene, expression units relative to the level of rrsH expression were calculated, and standard deviations are in parentheses. Gene name identifiers are based on EHEC strain
TW14359 (GenBank accession number NC_013008.1).
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Thus, control of GDAR by GrvA is relegated to exponential-phase
growth. In keeping with the requirement for rcsB in stationary-
phase GDAR, no growth was observed for TW14359 rcsB and
TW14359 grvA rcsB unless they were complemented with rcsB
(Fig. 5, bottom).
DISCUSSION
This study has examined aspects of grvA transcriptional regula-
tion, has defined the GrvA regulon, and has identified genetic
determinants underlying GrvA-dependent control of discrete
pathogenic mechanisms in EHEC. RcsB, the response regulator of
Rcs phosphorelay in E. coli, is predicted to directly activate tran-
scription of grvA, leading to the upregulation of LEE-dependent
adherence and repression of glutamate-dependent acid resistance
(Fig. 6). While it is not yet clear what cis-acting element(s) is re-
quired for RcsB-dependent activation of grvA, this study demon-
strated the binding of RcsB to a grvA promoter fragment contain-
ing two putative tandem RcsB binding sites located proximal to a
predicted 7035 site. These sites share some homology with the
RcsAB box consensus sequence described for rcsA, wza, and flhDC
promoters (30, 60), yet RcsA, which is highly unstable at elevated
temperatures (27), is not required for RcsB-dependent regulation
of the LEE (21), and RcsAB generally bind distal to and upstream
of the promoter core (31, 61, 62). The binding of RcsB to grvA
promoter fragments is more consistent with regulation as a ho-
modimer. RcsB homodimers bind a consensus sequence similar to
the RcsAB box and proximal to the35 site. Of the two putative
RcsB binding sites in the grvA promoter, the upstream site (Fig.
1B, Box 1) shares similarities with homodimer sites described for
osmC and rprA promoters (63). RcsB has also been shown to neg-
atively regulate grvA expression. In strains of E. coli O157:H7 har-
boring a 49-bp deletion in rcsB, trans-complementation with
wild-type rcsB decreased grvA expression (64). This was observed,
however, only during culture at 28°C and correlates with reduced
grvA expression during growth at 14°C and 25°C (65). Together,
this suggests that regulation of grvA by RcsB is temperature sensi-
tive. There is precedent for this, as repression of flhDC transcrip-
tion by RcsB occurs at both low and high temperatures. At low
temperatures, RcsB partners with RcsA (30), whereas at high tem-
peratures, the LEE-encoded regulator GrlA is required (20).
Overexpression of grvA increases transcription from the LEE1
promoter and correspondingly leads to increased adherence (21).
Consistent with this, RNA-seq analysis of TW14359 grvA in this
study revealed the reduced expression of genes belonging to both
the LEE1 and the LEE2-LEE3 operons, including LEE-encoded
regulator ler, T3S structural genes (esp genes), and the translo-
cated intimin receptor (tir) gene. This study is the first to show
that grvA deletion downregulates non-LEE-encoded T3S effector
genes (nle genes). These proteins broadly impact host signaling
cascades through inhibition of NF-B (NleC, NleE, NleD, and
NleH2) (66–68) and caspase activation (NleF) (69), as well as
interfere with host vesicle trafficking (NleA) (70). How these nle
genes are regulated by GrvA is unknown. One hypothesis is
through its regulatory effects on LEE expression. Both LEE-en-
coded activators Ler and GrlA regulate nleA expression (71–73).
Moreover, LEE-encoded GrlR has been shown to repress nleB and
nleH (71). However, non-LEE-encoded regulators involved in
quorum sensing (QseA) and nucleoid structuring (H-NS) have
also been implicated in the control of nle gene expression (71, 74).
Whatever the mechanism, these findings suggest a more compre-
hensive role for GrvA in EHEC pathogenesis that includes the
coordination of T3S-dependent colonization with immune sub-
version.
This study identifies GrvA to be a new regulator of glutamate-
dependent acid resistance (GDAR) genes (gad genes) (Fig. 6). De-
letion of grvA led to the upregulation of gad regulatory (gadE,
gadW and gadX) and enzymatic/structural (gadA and gadBC)
genes and corresponded with a 100-fold increase in acid survival
by the GDAR mechanism. These findings greatly expand the role
for GrvA in the pathogenic behavior of EHEC to include the con-
trol genes essential for the transmission of this pathogen in acidic
food matrices, gastric passage, and a low oral infectious dose.
Since grvA is needed for full bicarbonate induction of the LEE
(20), it is plausible that it helps to coordinate expression of the LEE
and GDAR systems upon entry into the intestine (Fig. 6).
Genes with no direct role in virulence were also shown to be
regulated by GrvA. Most notably, glnG (also ntrC) and nac expres-
sion was positively regulated by GrvA. Nitrogen regulatory pro-
FIG 3 GrvA requires gadE for control of LEE-dependent adherence. (A) ler
transcript levels determined by qRT-PCR plotted for TW14359, TW14359
grvA, TW14359 gadE, TW14359 grvA gadE, and complemented
strains TW14359 gadE/pgadE and TW14359 grvA gadE/pgadE grown in
DMEM (OD600  0.5). Plots which differ by lowercase letter differ signifi-
cantly by Tukey’s HSD test following a significant F test (n  3, P  0.05).
Error bars denote standard deviations. (B) Adherence ratio box plot for test
strains (TW14359 and genetic derivatives) relative to control strain TW14359
lacZ when cultured with HT-29 colonic epithelial cells (see the text for de-
tails). Box plot boundaries represent the 25th and 75th percentiles, whiskers
represent the maximum and minimum values, and the mean adherence ratio is
given by the horizontal line. Asterisks denote a significant difference compared
with the results for TW14359, as determined by t test (n 3; *, P 0.05; **,
P 0.01; ***, P 0.001).
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tein C (NtrC) is a transcriptional activator of nitrogen assimila-
tion control (Nac), and together these regulators are responsible
for coordinating the expression of genes for nitrogen metabolism
under limiting conditions (75). That ntrC and nac are positively
controlled by GrvA is consistent with the reduced expression of
operons for the utilization of glutamate (glt), glutamine (gln), ar-
ginine (ast), and asparagine (asn), as well as for the transport of
ammonium (amtB) observed in the TW14359grvA background.
How nitrogen availability influences GrvA-dependent control of
these mechanisms and the importance of grvA to nitrogen assim-
ilation are unknown.
GrvA was shown to activate LEE-encoded master regulator ler
through downregulation of gadE, the product of which directly
represses ler transcription in EHEC (52, 53, 76). Negative control
of gadE by GrvA is predicted to occur indirectly through the P3
promoter, requiring an intact gadW (Fig. 6). This is supported by
both gadE-lacZ promoter fusions and RNA-seq analysis in this
study. GadW is an AraC-family regulator that acts as a ho-
modimer or, when partnered with GadX, to control the acid fit-
ness genes gadBC, hdeA, hdeB, and gadE (54, 55, 77, 78). The
details of how GrvA regulates transcription are not yet known. For
FIG4 GrvA represses gadE transcription through GadW, determined from	-galactosidase activity (in Miller units) for gadE-lacZ promoter fusions in TW14359
and genetic derivatives. (A) (Top) Activity (in Miller units) for gadE-lacZ promoter fragments Frag-1 through Frag-4 and the vector control (pRS551) plotted for
TW14359 and TW14359 grvA during exponential-phase (OD600  0.5) and stationary-phase (OD600  2) growth in DMEM. (Bottom) Cartoon of the gadE
promoter and flanking regions. Promoter (P1 to P3) positions and the positions of each cloned promoter fragment (Frag-1 through Frag-4) relative to position
1 of the initiation codon for the gadEORF are indicated. (B) Activity (in Miller units) plotted for gadE-lacZ promoter fragments Frag-2 (left) and Frag-4 (right)
in TW14359 and mutant derivatives. For panels A and B, asterisks denote significant differences by t test (n 3; *, P 0.05; **, P 0.01). Bars denote standard
deviations. (C) Activity (in Miller units) plotted for the gadE-lacZ P3 promoter in TW14359 and mutant derivatives. Plots which differ by lowercase letter differ
significantly by Tukey’s HSD test following a significant F test (n 3, P 0.05).
FIG 5 GrvA is a growth phase-dependent repressor of acid resistance. Repre-
sentative colony-forming units on LB agar for TW14359 and derivative strains
following a 1-h challenge in EG medium (pH 7 versus pH 2) are shown. Cul-
tures were tested for acid resistance during exponential-phase (top) and sta-
tionary-phase (bottom) growth in DMEM. See the text for details.
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the regulation of gadW, there are two predicted promoters en-
coded in tandem and just upstream of the gadW (gadWP1 and
gadWP2) (77). It is suspected that gadWP1 is the target of GrvA
repression, as transcripts from this promoter, but not those from
gadWP2, were increased in TW14359grvA by RNA-seq (data not
shown). Multiple trans-acting factors are known to directly influ-
ence gadW transcription, including GadE, PhoP, and SdiA (acti-
vators) (79–81), as well as GadX, GadW, RutR, Fnr, and H-NS
(repressors) (77, 82–84). It is unlikely that gadX contributes to
GrvA-dependent repression of gadW, as gadX mutation in
TW14359 grvA was not observed to further alter gadE expres-
sion. Save for gadE, no other known regulators of gadW were
modified in expression by RNA-seq analysis, and a binding con-
sensus sequence for GrvA has yet to be defined. GrvA shares some
homology (29% identity, 79/270 amino acids) with MarT of Sal-
monella enterica serotype Typhimurium (85–87), most notably,
the first 150 residues of the N terminus containing a winged-helix
DNA-binding domain. marT is encoded on Salmonella pathoge-
nicity island 3 (SPI3), and its product is a direct transcriptional
activator of themisL autotransporter, which binds fibronectin and
increases intestinal colonization and invasiveness (88, 89). On the
basis of its similarity to CadC of E. coli, MarT is predicted to
activate misL by relieving H-NS-mediated repression (33). If the
regulation of gadW by GrvA is by a direct mechanism, however, it
is unlikely that H-NS is involved, as deletion of grvA increases
gadW expression. Future studies will be aimed at identifying cis
elements for GrvA-directed transcriptional regulation.
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